机构:[1]The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, China [2]Department of Oncology, The Fifth Affiliated Hospital of Guangxi Medical University & The First People’s Hospital of Nanning, Nanning, Guangxi, China[3]Department of Laboratory Medicine, Shengjing Hospital of China Medical University, No. 36, San Hao Street, Shenyang, Liaoning 110004, China 中国医科大学附属盛京医院中国医科大学盛京医院[4]Liaoning Clinical Research Center for Laboratory Medicine, Shenyang, China[5]Department of Respiratory Medicine, The Fifth Affiliated Hospital of Guangxi Medical University & The First People’s Hospital of Nanning, Nanning, Guangxi, China [6]The First Hospital of China Medical University, Shenyang, China [7]Liaoning University Of Traditional Chinese Medicine, Shenyang, China [8]The First Clinical College, China Medical University, Shenyang, China [9]Department of Medical Oncology, Cancer Hospital of China Medical University, China [10]Cancer Center, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[11]Department of Laboratory Animal Science, China Medical University, Shenyang, China
National Natural Science Foundation of China (No. 82073244, 81270036, 30901736), the Major Projects of Institute of Science and Technology, National Health Commission (2021KYSHX00601), Zhongnanshan Medical Foundation of Guangdong Province (ZNSA-2021014).
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
无
最新[2023]版:
大类|2 区医学
小类|1 区药学2 区医学:研究与实验
JCR分区:
出版当年[2024]版:
无
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[1]The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, China [2]Department of Oncology, The Fifth Affiliated Hospital of Guangxi Medical University & The First People’s Hospital of Nanning, Nanning, Guangxi, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Yang Chunjiao,Wu Lina,Jin Xin,et al.Decrease in GPSM2 mediated by the natural product luteolin contributes to colon adenocarcinoma treatment and increases the sensitivity to fluorouracil[J].BIOMEDICINE & PHARMACOTHERAPY.2024,176:116847.doi:10.1016/j.biopha.2024.116847.
APA:
Yang Chunjiao,Wu Lina,Jin Xin,Liu Aoran,Jing Zhitao...&Zhang Ye.(2024).Decrease in GPSM2 mediated by the natural product luteolin contributes to colon adenocarcinoma treatment and increases the sensitivity to fluorouracil.BIOMEDICINE & PHARMACOTHERAPY,176,
MLA:
Yang Chunjiao,et al."Decrease in GPSM2 mediated by the natural product luteolin contributes to colon adenocarcinoma treatment and increases the sensitivity to fluorouracil".BIOMEDICINE & PHARMACOTHERAPY 176.(2024):116847